{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:01:36Z","timestamp":1777104096189,"version":"3.51.4"},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2006,11,27]],"date-time":"2006-11-27T00:00:00Z","timestamp":1164585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> Daunorubicin is an anthracycline antitumour agent that can cause severe cardiomyopathy leading to a frequently fatal congestive heart failure. Although the exact molecular mechanisms of cardiotoxicity are not well established, oxidative mechanisms involving daunorubicin\u2010induced superoxide anion production have been proposed. In the present study, we showed that ebselen a seleno\u2010organic compound exhibiting glutathione peroxidase\u2010like and antioxidant activities, significantly ameliorated daunorubicin\u2010induced cardiomyopathy. Subcutaneous administration of ebselen to daunorubicin\u2010treated rats showed significant improvement in serum cardiac indices including creatine kinase isoenzyme and lactate dehydrogenase as well as serum glutathione (GSH) peroxidase. Moreover, myocardium of daunorubicin\/ebselen\u2010treated rats showed significant improvement in daunorubicin\u2010induced depletion of GSH peroxidase activity and reduced glutathione content, in addition to attenuation of daunorubicin\u2010induced increase in cardiac malondialdehyde production and total nitrate\/nitrite concentration levels. These results were confirmed by histopathological examination of ventricles of daunorubicin\/ebselen\u2010treated rats that revealed significant improvement of the characteristic cardiomyopathic changes induced by daunorubicin treatment. Interestingly, control rats treated with ebselen showed significant elevation in serum lactate dehydrogenase activity, cardiac malondialdehyde production and total nitrate\/nitrite concentration levels compared with the untreated control animals. In conclusion, ebselen treatment significantly alleviates daunorubicin\u2010induced cardiomyopathy.<\/jats:p>","DOI":"10.1111\/j.1742-7843.2006.pto_523.x","type":"journal-article","created":{"date-parts":[[2006,11,27]],"date-time":"2006-11-27T19:55:37Z","timestamp":1164657337000},"page":"412-417","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cardioprotective Effects of Subcutaneous Ebselen against Daunorubicin\u2010Induced Cardiomyopathy in Rats"],"prefix":"10.1111","volume":"99","author":[{"given":"Sherif Y.","family":"Saad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawfeeg A.","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha M.","family":"Arafah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,11,27]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2003.11.079"},{"key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1200\/JCO.1994.12.8.1659","article-title":"Comparative study of the pharmacokinetics and toxicity of high\u2010dose epirubicin with or without dexrazoxane in patients with advanced malignancy","volume":"12","author":"Basser R. L.","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.1999.5677"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.005728"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(94)00424-2"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-006-0199-4"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00309-3"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(59)90090-6"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.10500"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(03)00439-8"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/14756360500141994"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M106829200"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015976430790"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207936"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704495"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1006\/niox.2000.0319"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(03)00114-X"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(89)90108-2"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(79)90738-3"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.4.13.2210154"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000048192.52098.DD"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.04.003"},{"key":"e_1_2_5_24_1","first-page":"158","article-title":"Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase","volume":"70","author":"Paglia D. E.","year":"1967","journal-title":"J. Lab. Clin. Med."},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.005744"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(92)90427-K"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.2000.0769"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.20012"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.02096.x"},{"key":"e_1_2_5_30_1","first-page":"124","article-title":"Doxorubicin pharmacokinetics is altered differently by the cytoprotective agents amifostine or cardioxane (ICRF\u2010187) [abstract]","volume":"7","author":"Schuller J.","year":"1996","journal-title":"Ann. Oncol."},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00458-5"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2003.05.003"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.08.005"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1385\/CT:5:4:365"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi971475e"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.19.14064"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20020752"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200501000-00014"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.2000.1939"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2003.08.003"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2006.pto_523.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2006.pto_523.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T19:14:25Z","timestamp":1696965265000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2006.pto_523.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,27]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1111\/j.1742-7843.2006.pto_523.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2006.pto_523.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,27]]},"assertion":[{"value":"2006-11-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}